Most of us know someone whose life has been touched by ovarian cancer: it kills over 100,000 people each year and affects millions more.

But an Australian-invented blood test is giving us revolutionary insights into the differences between separate ovarian tumours. This could lead to life-saving early screenings and new treatments tailored to individual patients.

Dr Jessica Duarte from the Olivia Newton-John Cancer Research Institute and Adjunct Professor Els Meeusen from Federation University have worked with collaborators in Japan to create new ways to understand ovarian cancer at the immunological level.

TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.

Find out more at https://atse.org.au/TechNOW